Ainos Inc.以$5.4M的股票从TCNT收购了10项专利许可，增强了AI Nose和即时护理技术。 Ainos Inc. acquires 10 patent licenses from TCNT for $5.4M in shares, enhancing AI Nose and point-of-care tech.
该公司的共同开发商台湾碳纳米技术(TCNT)拥有10项发明专利和应用的独家许可证,涵盖美国、德国、中国、日本和台湾。 Healthcare firm Ainos Inc. obtains exclusive licenses for 10 invention patents and applications from Taiwan Carbon Nano Technology (TCNT), its co-developer, covering US, Germany, China, Japan, and Taiwan. 该交易涉及5.4M美元的股票以换取专利，这将提升Ainos的AI鼻子和即时检测技术。 The deal involves $5.4M shares in exchange for the patents, which will boost Ainos' AI Nose and point-of-care testing technologies. 全股许可证发放结构使TCNT的利益与Ainos的股东相一致,保留现金以换取增长。 The all-stock licensing structure aligns TCNT's interests with Ainos' shareholders, preserving cash for growth.